Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* DAVIS JAMES L	2. Issuer Name and Ticker or Trading Symbol ProUroCare Medical Inc. [ PUMD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ X __ Director __ X __ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) 6446 FLYING CLOUD DR	3. Date of Earliest Transaction (MM/DD/YYYY) 9/13/2013
(Street) EDEN PRAIRIE, MN 55344 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, $0.00001 par value								57482	I	Held by "Davis & Associates Inc." ⁽²⁾
Common Stock, $0.00001 par value								169964	I	Held by "Davis & Associate 401K PSP" ⁽²⁾
Common Stock, $0.00001 par value	9/13/2013		P		2500	A	$0.18	2700864	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Warrants	$2.00							⁽¹⁾	10/31/2013	Common Stock, $0.00001 par value	16667		16667	D
Warrants	$1.50							⁽¹⁾	9/25/2013	Common stock, $0.00001 par value	100000		100000	D
Warrants	$1.30							⁽¹⁾	1/7/2014	Common Stock, $0.00001 par value	195000		195000	D
Options	$2.41							⁽¹⁾	3/1/2017	Common stock, $0.00001 par value	10374		10374	D
Warrant	$1.30							⁽¹⁾	7/12/2013	Common stock, $0.00001 par value	100000		100000	D
Warrant	$1.30							⁽¹⁾	7/12/2013	Common stock, $0.00001 par value	20000		20000	I	Held by "Davis & Associates Inc. 401(k) PSP" ⁽²⁾
Warrant	$1.30							⁽¹⁾	7/12/2013	Common stock, $0.00001 par value	20000		20000	I	Held by "Davis & Associates Inc." ⁽²⁾
Warrants	$1.30							⁽¹⁾	8/2/2013	Common stock, $0.0001 par value	286923		286923	D
Warrants	$1.30							⁽¹⁾	1/7/2014	Common stock, $0.00001 par value	54964		54964	I	Held by "Davis & Associates Inc. 401K PSP" ⁽²⁾
Warrants	$1.30							⁽¹⁾	8/2/2013	Common stock, $0.0001 par value	20000		20000	I	Held by Davis & Associates, Inc. 401(k) PSP ⁽²⁾
Warrants	$1.30							⁽¹⁾	1/7/2014	Common stock, $0.00001 par value	17482		17482	I	Held by "Davis & Associates Inc." ⁽²⁾
Warrants	$1.30							⁽¹⁾	8/2/2013	Common stock, $0.0001 par value	20000		20000	I	Held by Davis & Associates, Inc. ⁽²⁾
Options	$1.72							⁽¹⁾	8/10/2017	Common stock, $0.00001 par value	14535		14535	D
Warrants	$1.30							⁽¹⁾	1/7/2014	Common stock, $0.00001 par value	50000		50000	D
Stock options	$0.87							⁽¹⁾	8/9/2018	Common stock, $0.00001 par value	28736		28736	D
Convertible Note	$1.30							⁽¹⁾	9/20/2013	Common stock, $0.00001 par value	⁽³⁾		$150000	D
Warrant	$1.30							⁽¹⁾	1/7/2014	Common stock, $0.00001 par value	62923		62923	D
Convertible Note	$1.30							⁽¹⁾	3/31/2014	Common stock, $0.00001 par value	⁽⁵⁾		$100000	D
Stock Options	$0.60							⁽⁴⁾	8/9/2019	Common stock, $0.00001 par value	25000		25000	D
Warrant	$0.50							⁽¹⁾	4/27/2018	Common Stock, $0.00001 par value	340998		56833	D
Warrant	$0.50							⁽¹⁾	4/27/2013	Common stock, $0.00001 par value	291670		632668	D
Warrant	$0.50							⁽⁶⁾	4/27/2018	Common stock, $0.00001 par value	295313		295313	D

Explanation of Responses:
( 1)	Currently exercisable
( 2)	Reporting person is the Sole owner of Davis & Associates Inc. and has sole voting power.
( 3)	The Reporting Person holds $150,000, of 10% convertible secured subordinated promissory notes from the Issuer. The promissory note and any accrued interest thereon is convertible at any time at the option of the reporting person into common stock at $1.30 per share. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The Issuer's Board of Directors specifically approved the reporting person's participation in the private placement as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).
( 4)	Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors. The seven-year options vest ratably over the 12 month period from Sepetember 2013 to August 2014.
( 5)	The Reporting Person holds $100,000, of 10% convertible secured subordinated promissory notes from the Issuer. The promissory note and any accrued interest thereon is convertible at any time at the option of the reporting person into common stock at $1.30 per share. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The Issuer's Board of Directors specifically approved the reporting person's participation in the private placement as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).
( 6)	The issuer issued the warrants to the Reporting Person as consideration for a $450,000 loan guarantee for the period from April 1, 2013 to February 15, 2014. The warrants will vest as to 28,125 shares on the first of each month from April 2013 to January, 2014, and as to 14,063 share on February 1, 2014, subject to adjustment if the amount of the loan guaranteed should change. The issuer's Board of Directors specifically approved the reporting person's participation in the private placement as exempt from the requirements of Section 16b as provided by Rules 16b-3(d) and 16b-3(e).

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
DAVIS JAMES L 6446 FLYING CLOUD DR EDEN PRAIRIE, MN 55344	X	X

Signatures
/s/ Alan Shuler, Attorney in Fact for James L. Davis		9/17/2013
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.